✦ LIBER ✦

Efficacy and safety of sorafenib–gemcitabine combination therapy in advanced hepatocellular carcinoma: An open-label Phase II feasibility study

✍ Scribed by Naqi, Naeem; Ahmad, Shaharyar; Murad, Sohail; Khattak, Javaid

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of sunitinib in pati

✍ Sandrine Faivre; Eric Raymond; Eveline Boucher; Jean Douillard; Ho Y Lim; Jun S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 178 KB

An open-label phase I/II study of tamiba

✍ Fumihiko Kanai, Shuntaro Obi, Shigetoshi Fujiyama… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 476 KB

Phase 2 Study of Combined Sorafenib and

✍ Chen, Shang-Wen; Lin, Li-Ching; Kuo, Yu-Cheng; Liang, Ji-An; Kuo, Chia-Chun; Chi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Phase II, open-label study of brivanib a

✍ Jairo A. Garcia; Lewis R. Roberts 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A phase II open label trial evaluating s

✍ Tim F Greten; Alejandro Forner; Firouzeh Korangy; Gisele N'Kontchou; Nathalie Ba 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 790 KB

Efficacy and safety of viscum fraxini-2

✍ Mohamed A. Ebrahim; Hend A. El-Hadaad; Omyma A. Alemam; Salah A. Keshta 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 332 KB